Skip to main content

Elisabeth ("Lis") Leiderman, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Autolus Therapeutics plc publishes a filing, an earnings call transcript or a press release.

Get AUTL alerts

About Elisabeth ("Lis") Leiderman, M.D.

Elisabeth ("Lis") Leiderman, M.D. is recorded as Board Member at Autolus Therapeutics plc (AUTL) since December 20, 2023. Autolus Therapeutics plc reported in an 8-K filed December 22, 2023 that Elisabeth ("Lis") Leiderman, M.D. was appointed Class II director, effective December 20, 2023. Autolus Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Autolus Therapeutics plc includes Michael W. Bonney (Chairman and Board Member), Patrick McIlvenny (Chief Accounting Officer), Rob Dolski (Chief Accounting Officer) and 3 others.

“On December 22, 2023, the Company announced that the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Elisabeth ("Lis") Leiderman, M.D. to serve as a Class II director of the Company, effective December 20, 2023.”
Autolus Therapeutics plc Form 8-K, filed December 22, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Autolus Therapeutics plc

Recent activity